Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY) Stock Short Interest Report for October

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY) was the target of a large decline in short interest in the month of October. As of October 30th, there was short interest totaling 4,226 shares, a decline of 92.6% from the October 15th total of 57,367 shares. Based on an average daily volume of 50,823 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.0% of the shares of the company are short sold.

Otsuka Stock Performance

Shares of OTSKY traded down $0.39 during mid-day trading on Tuesday, reaching $37.68. 47,319 shares of the company’s stock traded hands, compared to its average volume of 41,408. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.65 and a current ratio of 2.21. The business’s 50-day moving average price is $37.29 and its 200-day moving average price is $35.10. The stock has a market capitalization of $40.48 billion, a P/E ratio of 16.17, a price-to-earnings-growth ratio of 2.75 and a beta of 0.08. Otsuka has a 12 month low of $26.11 and a 12 month high of $40.92.

Otsuka (OTCMKTS:OTSKY) last posted its earnings results on Friday, October 30th. The company reported $0.64 EPS for the quarter, beating the consensus estimate of $0.59 by $0.05. The firm had revenue of $4.51 billion for the quarter, compared to analysts’ expectations of $4.42 billion. Otsuka had a return on equity of 11.90% and a net margin of 14.36%. Equities analysts predict that Otsuka will post 2.21 earnings per share for the current year.

Analyst Ratings Changes

Separately, Zacks Research upgraded Otsuka from a “hold” rating to a “strong-buy” rating in a research note on Friday, October 9th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Otsuka currently has a consensus rating of “Moderate Buy”.

Otsuka Company Profile

Otsuka Holdings Co., Ltd. is a Japan-based holding company whose businesses focus primarily on pharmaceuticals and nutraceuticals. Its group companies research, develop, manufacture, and market prescription medicines, consumer health products, and medical devices. Otsuka’s pharmaceutical portfolio includes treatments across areas such as mental health, kidney disease, and oncology. Its nutraceutical business offers products including Pocari Sweat and CalorieMate, alongside other nutrition and wellness products.